A 35-year-old man with Bipolar Disorder II is on lamotrigine 100 mg daily and has been euthymic for 8 months. He now presents with 2 weeks of elevated mood, increased goal-directed activity, reduced sleep need (5 hours), and mild irritability, but no psychotic features. He denies substance use. What is the most appropriate next step in management?

Explanation

## Management of Emerging Hypomania in Bipolar Disorder II on Lamotrigine **Key Point:** Before escalating or switching therapy, evaluate for non-pharmacological causes (poor adherence, stressors, sleep deprivation, substance use) and verify therapeutic drug levels. ### Clinical Context: Bipolar Disorder II **High-Yield:** Bipolar II is defined by hypomanic episodes (not full manic episodes) alternating with major depressive episodes. Hypomanic episodes are shorter (≥4 days vs ≥7 days for mania) and cause less functional impairment. - Lamotrigine is particularly effective for bipolar II depression and maintenance [cite:Gijsman et al., Cochrane Review on Lamotrigine in Bipolar Disorder] - The patient's current presentation (2 weeks of hypomania) may represent: - Inadequate lamotrigine level (subtherapeutic) - Poor adherence - Environmental stressor or sleep disruption triggering mood destabilization - True breakthrough hypomanic episode despite adequate therapy ### Rationale for Correct Answer **Mnemonic: ASSESS before ESCALATE** - **A**dheren**ce** check - **S**erum drug level - **S**tressors and sleep - **E**nvironmental triggers - **S**ubstance use - **S**omatically (thyroid, metabolic) 1. **Serum lamotrigine level:** Therapeutic range 4–20 μg/mL. Subtherapeutic levels are common due to poor adherence or drug interactions. 2. **Thyroid function:** Hypothyroidism can destabilize mood in bipolar patients and is a known risk with some mood stabilizers. 3. **Assess adherence and stressors:** Non-pharmacological triggers (sleep loss, stress, substance use) are major causes of mood episode breakthrough. 4. **Decide next step based on findings:** - If subtherapeutic level → increase lamotrigine or optimize adherence - If therapeutic level + adherent + no stressors → consider augmentation with antipsychotic - If thyroid dysfunction → treat thyroid disorder **Clinical Pearl:** Jumping to drug escalation without investigating the cause of breakthrough symptoms is a common error and may lead to polypharmacy without benefit. --- ## Comparison: Management Approaches | Approach | Indication | Rationale | |----------|-----------|----------| | Increase lamotrigine | Subtherapeutic level + good adherence | Dose-dependent efficacy | | Add antipsychotic | Therapeutic lamotrigine + breakthrough hypomania | Augmentation for inadequate response | | Assess first (correct answer) | Unknown cause of breakthrough | Prevents unnecessary escalation; identifies reversible causes | | Switch to lithium | Lamotrigine failure despite optimization | Premature; lithium is more effective for bipolar I mania than bipolar II | --- ## Why Each Distractor Is Wrong